Neurocrine Biosciences (NBIX) Return on Invested Capital (2020 - 2024)
Neurocrine Biosciences (NBIX) posted quarterly Return on Invested Capital of 0.02% for Q4 2024, up 2.0% year-over-year from 0.02% in Q1 2024, and up 70.08% on a QoQ basis from 0.01% in Q3 2024.
Neurocrine Biosciences (NBIX) Return on Invested Capital (2020 - 2024) Analysis & Trends
Neurocrine Biosciences has reported Return on Invested Capital for 5 years, with the latest figure at 0.02% in Q4 2024.
- Return on Invested Capital for Q4 2024 came in at 0.02%, up 2.0% year-over-year; the trailing twelve-month figure through Dec 2024 was 0.02% (up 2.0% YoY), and the FY2023 annual result was 0.01%, changed N/A from the prior year.
- Return on Invested Capital climbed to 0.02% in Q4 2024, from 0.01% in the prior quarter.
- Over five years, Return on Invested Capital peaked at 0.02% in Q4 2024 and troughed at 0.0% in Q3 2020.
- A 5-year average of 0.01% and a median of 0.01% in 2020 frame the typical range for Return on Invested Capital.
- The widest annual swing landed in 2021, when Return on Invested Capital changed 0 bps; it then grew 2 bps in 2024.
- A 5-year view of Return on Invested Capital shows it stood at 0.01% in 2020, then surged by 70 bps to 0.01% in 2021, then declined by 30 bps to 0.01% in 2022, then plunged by 48 bps to 0.0% in 2023, then surged by 420 bps to 0.02% in 2024.
- Per Business Quant data, the three most recent Return on Invested Capital figures were 0.02% in Q4 2024, 0.01% in Q3 2024, and 0.01% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 0.00% |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 0.00% |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 0.00% |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 0.03% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | 0.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.02% |
| Sep 30, 2024 | 0.01% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | 0.01% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.01% |
| Jun 30, 2021 | 0.01% |
| Mar 31, 2021 | 0.01% |
| Dec 31, 2020 | 0.01% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.01% |